Overseeing site identification for oncology, neurology, cardiovascular, hematology, infectious disease, mental disease, musculoskeletal disease and dermatology studies in phases II-IV. Feasibility. Managing teams of site contact associates in EU, USA and APAC for the collection and collation of internal and external information and evidence to support site identification. Ensure standard processes, tools and procedures are used consistently for study execution. Building relationships with researchers / sites and networks in European countries for conducting feasibility studies.